Bildnachweis: ECBF.
Bioeconomy-focused venture capital investor ECBF VC has opened an office in Paris and unveiled a renewed brand identity. With this step, the fund aims to further strengthen its position as a leading European VC platform for the bioeconomy and expand its activities in France.
France is now considered one of Europe’s strongest deeptech ecosystems, supported by world-class research institutions, industrial champions and a rapidly maturing venture landscape. For ECBF, this momentum is already visible: four portfolio companies – Elicit Plant, ecoat, RED Horticulture and Weenat – are based in France and are developing innovations in sustainable agriculture, bio-based materials and climate-smart technologies. By opening the Paris office, the fund formalises its long-term commitment to the country. The local presence is intended to deepen collaboration with French VC partners, industrial players and research institutions, while strengthening deal sourcing. “France has evolved into one of Europe’s most dynamic bioeconomy ecosystems,” said Stéphane Roussel, Partner at ECBF, who will lead the Paris office together with Guillaume Gras and Charlotte Rossignol. “By establishing a permanent presence here, we are strengthening our proximity not only to entrepreneurs, but also to the broader French VC network. Our ambition is to deepen our activities in France and actively contribute to building a stronger and more connected bioeconomy investment ecosystem.”
Next phase of growth
At the same time, ECBF is positioning itself for its next phase of growth. As the bioeconomy gains strategic importance across Europe, demand is rising for specialist capital capable of bridging scientific innovation, industrial applications and scalable business models. By strengthening its presence in France and sharpening its positioning, ECBF aims to foster cross-border collaboration and mobilise institutional and industrial capital. Since its launch, the fund has invested in 25 companies across sectors including food systems, industrial biotechnology, bio-based materials and circular value chains. Its objective is to support companies in scaling globally while combining environmental impact with strong financial performance. The renewed brand identity, including a redesigned logo, website and communication framework, reflects this development. “We are not a generalist impact fund,” said Michael Brandkamp, General Partner of ECBF. “We are a specialist VC dedicated exclusively to the bioeconomy. Europe’s industrial transformation requires focused capital, scientific understanding and long-term conviction. That is exactly what we stand for.”
